M
$ Value
$0
Shares
62,500
Price
$0
Filed
Apr 6
Insider
Name
Collard Craig A
Title
Chief Executive Officer
CIK
0001363558
Roles
Director
Officer
Transaction Details
Transaction Date
2026-04-03
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
62,500
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock. | Includes 14,045 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2025. | The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date.
Filing Info
Collard Craig A's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-19 | HRTX | M | — |
| 2026-04-19 | HRTX | M | $0 |
| 2026-04-03 | HRTX | M | — |
| 2026-04-03 | HRTX | M | $0 |
| 2026-01-31 | HRTX | M | — |
| 2026-01-31 | HRTX | M | $0 |
| 2026-01-30 | HRTX | A | $0 |
| 2026-01-30 | HRTX | A | $0 |
| 2026-01-19 | HRTX | M | — |
| 2026-01-19 | HRTX | M | $0 |
Other Insiders at HRTX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Forbes William P
EVP, Chief Development Officer
|
— | — | 2026-04-19 |
|
Collard Craig A
Chief Executive Officer
|
— | — | 2026-04-19 |
| Johnson Craig A | — | — | 2026-01-30 |
|
Duarte Ira
EVP, Chief Financial Officer
|
— | — | 2026-04-19 |
| Christian Waage | — | — | 2026-01-30 |
| Kaseta Michael | — | — | 2026-01-30 |
| Dissanaike Sharmila | — | — | 2026-01-30 |
| Morgan Adam | — | — | 2026-01-30 |
|
Hensley Mark Earl
Chief Operating Officer
|
— | — | 2026-01-30 |
| Cusack Thomas | — | — | 2026-01-30 |